Cell-based gene therapy experiments in murine experimental autoimmune encephalomyelitis.

Area of Science:

• Immunology
• Neuroscience
• Gene Therapy

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• Experimental autoimmune encephalomyelitis (EAE) serves as a key animal model for studying MS pathogenesis and testing potential therapies.

Purpose of the Study:

• To develop and evaluate a cell-based gene therapy protocol for treating EAE.
• To investigate the efficacy of transduced fibroblasts secreting specific antigens in ameliorating EAE.
• To optimize the gene delivery system for potential clinical translation in MS treatment.

Main Methods:

• Development of fibroblast cell lines engineered to secrete encephalitogenic epitopes (from myelin basic protein and proteolipid protein).
• Administration of these transduced fibroblasts to mice with established EAE.
• Evaluation of disease severity and therapeutic effects.
• Testing of sequestered cells within implantable chambers and modified mini-gene constructs.

Main Results:

• Injected transduced fibroblasts significantly abrogated EAE disease progression.
• Both myelin basic protein and proteolipid protein mini-gene constructs were effective in ameliorating EAE.
• Therapeutic efficacy was observed with both syngeneic and allogeneic cells, particularly when sequestered in implantable chambers.
• Modification of signal sequences reduced the required cell dose for effective treatment.

Conclusions:

• Cell-based gene therapy using engineered fibroblasts is a viable strategy for treating EAE.
• The approach demonstrates potential for novel therapeutic interventions in multiple sclerosis.
• Optimizations in cell delivery and antigen expression enhance the feasibility of clinical application.